SIPO Commissioner Tian Lipu met Pfizer Senior Vice President Roy F. Waldron in Beijing. Tian appreciated Pfizer's confidence in China's IPR protection and wished the global pharmaceutical giant more IPR cooperation with Chinese companies. Waldron expressed his gratitude to SIPO's efforts in advancing IPR development and said that their Chinese subordinate invest more than 1 billion U.S. dollars in R&D.

 

(China IP News)

2011-11-03

2011-11-03